Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039935 | SCV000063626 | benign | not specified | 2012-01-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000039935 | SCV000114338 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039935 | SCV000516619 | benign | not specified | 2016-04-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000462609 | SCV000555621 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000039935 | SCV000616015 | benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839528 | SCV002099930 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839529 | SCV002099931 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839530 | SCV002099932 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839527 | SCV002099934 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing |